Update on the clinical efficacy and side effects of clozapine.
about
Clozapine for psychotic disorders in adults with intellectual disabilitiesPharmacological interventions for clozapine-induced sinus tachycardiaAnticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophreniaAnticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophreniaPharmacological interventions for clozapine-induced sinus tachycardiaEffectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case seriesRare and very rare adverse effects of clozapineA retrospective study of clozapine and urinary incontinence in Chinese in-patientsUnrecognized clozapine-related constipation leading to fatal intra-abdominal sepsis - a case report.Use of aripiprazole in clozapine induced enuresis: report of two cases.Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series.Clinical features of schizophrenia with enhanced carbonyl stress.The pharmacology and toxicology of atypical antipsychotic agents.Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia: a multicentre cross-sectional cohort study.The history of clozapine and its emergence in the US market: a review and analysis.Clozapine prescribing in the UK: views and experience of consultant psychiatrists.Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine.A review of clozapine safety.Clozapine-induced sialorrhea: pathophysiology and management strategies.Clozapine-induced hypersalivation: a review of treatment strategies.Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intakeClozapine-induced bowel infarction: a case reportModafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trialThe receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.Where to position clozapine: re-examining the evidence.Aripiprazole-induced seizure: a second case report.Clozapine for the treatment of schizophrenia.A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections.Rapid Clozapine Titration in Patients with Treatment Refractory Schizophrenia.Drug strategies and treatment-resistant schizophrenia.Clozapine therapy in patients with neurologic illness.Dose-Dependent Clozapine-Induced Supraventricular Tachycardia.Managing pathologic aggression in people with psychotic disorders.Extrapyramidal side effects of clozapine and haloperidol.Patterns of clozapine prescribing in a mental health service in New Zealand.
P2860
Q24187048-EC79C775-47AE-4712-96E7-A43687AC02ACQ24187704-5FC45E5B-3C83-466F-9D52-AA4AEA4BDA1CQ24201675-B8F7CCF7-37A3-49A5-BDCC-9D62F457F490Q24203826-DF039656-7729-4A47-877C-3E0BAC247892Q26471506-D7466E30-EC3E-48AA-B0F3-93E50E2E5AC9Q26795393-EDCF811F-5339-4CFA-849E-7FCF29D9C43EQ26798339-DF1099B3-3CC9-4ADF-A482-6F22B533C0ADQ28372600-6936B0CB-58DE-4084-8AD1-47A9EA26721BQ33166261-D049888C-0F5F-4F75-BCAC-E2BBFB9D6BC5Q33610091-DE76DCB9-6C64-4A0E-974A-AAA4A381CEEDQ33937346-4CC78B19-69CB-4EDF-89A8-3D7EF3152B64Q34048575-D8CC9395-C43A-4498-A9DC-D713F102FBD2Q34235349-48750E9C-B064-4A27-9E2E-39131B1FC1BFQ34333212-F47F3D98-A09D-42B0-9CD3-5BDA6C323370Q34639662-87A46515-CD6F-4B14-91F0-83619C2D7603Q35906545-0EA899DE-E13C-4FD7-9AC0-6B58BFC14DB4Q36013784-5AD473A4-76E6-4A24-9347-552D78135CE7Q36191044-743A6017-945A-4BEB-B3E0-A33DB1E31BB1Q36412431-44189A3B-380B-4704-843A-AAA01B294416Q36908979-A69DDA05-A361-498E-BA38-3C86E68F6183Q37162884-5DE6A326-A050-4292-AFA1-44B2DF9AEEACQ37172329-17F740B1-BC2B-4521-B8F0-E65C910429FFQ37285391-F3B833AA-FB94-4A64-B150-933F9A1333F8Q37287980-44283C85-D3DA-432B-845A-97236DFC0D04Q37345260-25B669DE-F901-41B2-87D9-9B065BF6E3A9Q37426278-4DC626F8-E137-45C4-896B-EF60CA566314Q37801988-7D1B4A6C-A9E2-45CD-8F55-8E4330CBD619Q37900852-62B112FF-2DC8-4C41-9AE8-897D80344CAAQ38026886-F9590836-792E-475A-A30D-BC2F05BFA151Q38132166-95CE479A-7E97-4753-8D04-7D7E72C82258Q38218540-B224B11C-470A-48F3-9B10-24081A4FF68EQ38916126-F7E139FC-67EB-4E33-A9F7-E2CFD12DFFF9Q38948365-361A84BA-BA15-439E-B44A-0B7C0ACBEF77Q40470408-E3A37F2B-F437-4D9E-AF30-1714B4ED8F60Q41047105-4E5EB068-DC7E-4401-B29C-2DE2CB8F6803Q41122440-4183061D-2194-4C35-9293-0833A67601F4Q41176394-6461DCBD-D9CF-4B6B-BA3E-FDF9ECA70BC7Q41859787-39AFCF82-1F56-4AF3-961A-7D79A2CD20F0Q42276817-9B5D3DB4-8686-4BA7-8141-394D77BD5120Q43043460-025CEEBD-0C96-4DAE-8F7C-953C9304233E
P2860
Update on the clinical efficacy and side effects of clozapine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update on the clinical efficacy and side effects of clozapine.
@en
Update on the clinical efficacy and side effects of clozapine.
@nl
type
label
Update on the clinical efficacy and side effects of clozapine.
@en
Update on the clinical efficacy and side effects of clozapine.
@nl
prefLabel
Update on the clinical efficacy and side effects of clozapine.
@en
Update on the clinical efficacy and side effects of clozapine.
@nl
P2093
P356
P1476
Update on the clinical efficacy and side effects of clozapine.
@en
P2093
P304
P356
10.1093/SCHBUL/17.2.247
P407
P577
1991-01-01T00:00:00Z